1.07
price up icon1.90%   0.02
after-market アフターアワーズ: 1.09 0.02 +1.87%
loading
前日終値:
$1.05
開ける:
$1.09
24時間の取引高:
9,597
Relative Volume:
0.80
時価総額:
$9.18M
収益:
-
当期純損益:
-
株価収益率:
-1.5087
EPS:
-0.7092
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-8.55%
1か月 パフォーマンス:
-12.30%
6か月 パフォーマンス:
-45.44%
1年 パフォーマンス:
-55.04%
1日の値動き範囲:
Value
$1.07
$1.10
1週間の範囲:
Value
$1.05
$1.24
52週間の値動き範囲:
Value
$1.01
$5.41

Alterity Therapeutics Ltd Adr Stock (ATHE) Company Profile

Name
名前
Alterity Therapeutics Ltd Adr
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
10
Name
Twitter
@AlterityT
Name
次回の収益日
2024-08-29
Name
最新のSEC提出書
Name
ATHE's Discussions on Twitter

ATHE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ATHE 1.07 9.18M 0 0 0 -0.7092
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

Alterity Therapeutics Ltd Adr (ATHE) 最新ニュース

pulisher
Nov 19, 2024

Alterity Therapeutics announces change in company secretary - Investing.com

Nov 19, 2024
pulisher
Nov 15, 2024

Opthea adds Kathy Connell to Board of Directors - Investing.com

Nov 15, 2024
pulisher
Oct 15, 2024

Alterity Therapeutics to join Maxim Healthcare Summit - Investing.com

Oct 15, 2024
pulisher
Oct 14, 2024

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.

Oct 14, 2024
pulisher
Oct 04, 2024

Alterity Therapeutics announces change in share registry - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Alterity Therapeutics announces change in share registry By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 01, 2024

Opthea Ltd stock soars to 52-week high, hits $4.47 - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Alterity Therapeutics names new CFO - Investing.com India

Oct 01, 2024
pulisher
Sep 26, 2024

Alterity Therapeutics discloses annual report for 2024 - Investing.com

Sep 26, 2024
pulisher
Jul 19, 2024

Alterity Therapeutics announces regulatory notice filing - Investing.com

Jul 19, 2024
pulisher
Jul 18, 2024

ATHE’s Stock Market Adventure: -14.26% YTD Growth Amidst Volatility - The InvestChronicle

Jul 18, 2024
pulisher
Jul 17, 2024

Alterity reports positive Phase 2 trial interim data - Investing.com

Jul 17, 2024
pulisher
Jul 15, 2024

Alterity Therapeutics announces trading halt - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Alphabet stock cited by TD Cowen amid potential Wiz acquisition - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Alterity Therapeutics announces trading halt By Investing.com - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Avenue Supermarts stock target raised by Nuvama, still a Hold - Investing.com India

Jul 15, 2024
pulisher
Jul 15, 2024

Wolfe Research keeps Peerperform rating on Goldman Sachs stock, notes mixed Q2 earnings - Investing.com India

Jul 15, 2024
pulisher
Jun 17, 2024

RBC Capital sees growth potential in Bowhead Specialty shares - Investing.com

Jun 17, 2024
pulisher
Jun 12, 2024

ATHEAlterity Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jun 12, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Feb 15, 2024

Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners - Stockhead

Feb 15, 2024
pulisher
Jan 02, 2024

ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024 - Stockhead

Jan 02, 2024
pulisher
Nov 20, 2023

Closing Bell: The ASX is slightly higher, but not much cooler on Monday - Stockhead

Nov 20, 2023
pulisher
Aug 17, 2023

Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead

Aug 17, 2023
pulisher
Jan 06, 2023

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire

Jan 06, 2023
pulisher
Mar 19, 2020

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance

Mar 19, 2020
pulisher
Mar 17, 2020

The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga

Mar 17, 2020
pulisher
Jan 12, 2020

Check up: Enthusiasm rather than news is moving health stocks - Stockhead

Jan 12, 2020
pulisher
Jan 03, 2020

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

Jan 03, 2020
pulisher
Dec 19, 2019

The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For An - Benzinga

Dec 19, 2019
pulisher
Jul 30, 2019

54 Biggest Movers From YesterdayAcasti Pharma (NASDAQ:ACST), Alterity Therapeutics (NASDAQ:ATHE) - Benzinga

Jul 30, 2019

Alterity Therapeutics Ltd Adr (ATHE) 財務データ

Alterity Therapeutics Ltd Adr (ATHE) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):